MiMedx Group
MDXG
#4981
Rank
$1.36 B
Marketcap
$9.28
Share price
0.54%
Change (1 day)
40.61%
Change (1 year)
Categories

P/E ratio for MiMedx Group (MDXG)

P/E ratio as of November 2024 (TTM): -381

According to MiMedx Group's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -380.543. At the end of 2022 the company had a P/E ratio of -8.42.

P/E ratio history for MiMedx Group from 2008 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-8.42-79.08%
2021-40.3241.47%
2020-11.8-64.22%
2019-33.0418.61%
2018-6.35-130.74%
201720.7-99.14%
2016> 10007090.65%
201533.5-83.66%
2014205-201.13%
2013-202374.52%
2012-42.7390.86%
2011-8.6922.34%
2010-7.11162.8%
2009-2.70

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
22.2-105.84%๐Ÿ‡บ๐Ÿ‡ธ USA
32.1-108.43%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
73.6-119.34%๐Ÿ‡บ๐Ÿ‡ธ USA
180-147.27%๐Ÿ‡ฎ๐Ÿ‡ช Ireland

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.